Vyome Biosciences raises $8 million from Sabre Partners, existing investors
1 min read . Updated: 11 Aug 2014, 05:19 PM IST
PremiumThe company will use the funds for advanced clinical research, development of better products, and innovative commercialization strategies
Vyome Biosciences, a New Delhi-based dermatology company, announced on Monday that it has raised $8 million in funding. This round of funding was led by Sabre Partners, with participation from existing investors Kalaari Capital and Aarin Capital.
The company will use the funds for advanced clinical research, development of better products, and innovative commercialization strategies, N. Venkat, chief executive officer and co-founder, Vyome, said in a statement.
“The company is applying science and critical understanding to develop unique platform technologies and products for the $20 billion global dermatology market," said Rajiv Maliwal, founder and managing partner, Sabre Partners in a statement.
The company had raised ₹ 18.5 crore from IndoUS Venture Partners, with participation from Aarin Capital and Navam Capital in 2012.
